Peginterferon beta-1a
Plegridy (peginterferon beta-1a) is a protein pharmaceutical. Peginterferon beta-1a was first approved as Plegridy on 2014-07-17. It is used to treat multiple sclerosis in the USA. It has been approved in Europe to treat multiple sclerosis.
| Trade Name | Plegridy |
|---|---|
| Common Name | Peginterferon beta-1a |
| Indication | multiple sclerosis |
| Drug Class | Pegylated compounds |
